We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Monster Beverage
MNST
$92.3B
| $45.4M | 0.26% |
2,030,568
-1,558,326
| -43% | -$34.8M |
|
|
LPNT
102
DELISTED
LifePoint Health, Inc.
LPNT
| $45.2M | 0.26% |
519,304
-59,525
| -10% | -$4.5M |
|
103
Vertex Pharmaceuticals
VRTX
$121B
| $45.1M | 0.26% |
365,423
+184,958
| +102% | +$23.3M |
|
104
Vodafone
VOD
$36.3B
| $45.1M | 0.25% |
1,237,223
+1,164,923
| +1,611% | +$42M |
|
105
Canadian Pacific Kansas City
CP
$79.6B
| $44.8M | 0.25% |
1,398,470
-1,506,660
| -52% | -$53.8M |
|
106
Pfizer
PFE
$145B
| $43.8M | 0.25% |
+1,377,156
| New | +$44.9M |
|
107
BioMarin Pharmaceuticals
BMRN
$11.7B
| $43.8M | 0.25% |
+319,900
| New | +$39.6M |
|
108
Burlington
BURL
$23.2B
| $43.7M | 0.25% |
852,616
-118,964
| -12% | -$6.36M |
|
109
AvalonBay Communities
AVB
$26.9B
| $43.4M | 0.25% |
271,658
-53,099
| -16% | -$8.84M |
|
110
Genworth Financial
GNW
$3.76B
| $42.2M | 0.24% |
5,580,699
+4,298,250
| +335% | +$34.3M |
|
111
GSK
GSK
$103B
| $41.8M | 0.24% |
+801,938
| New | +$45.2M |
|
112
Moody's
MCO
$83.8B
| $41.5M | 0.23% |
384,153
+165,343
| +76% | +$17.8M |
|
|
CTXS
113
DELISTED
Citrix Systems Inc
CTXS
| $41.1M | 0.23% |
736,176
+224,358
| +44% | +$11.9M |
|
|
GRFS
114
Grifois
GRFS
$5.53B
| $40.4M | 0.23% |
2,611,922
+25,920
| +1% | +$420K |
|
115
Bath & Body Works
BBWI
$4.22B
| $39.9M | 0.23% |
575,751
+177,599
| +45% | +$12.7M |
|
116
BlackBerry
BB
$5.19B
| $38.8M | 0.22% |
4,749,158
-1,563,564
| -25% | -$15.1M |
|
117
Essex Property Trust
ESS
$18.4B
| $37.9M | 0.21% |
178,230
-55,124
| -24% | -$12.2M |
|
118
VeriSign
VRSN
$27B
| $36.8M | 0.21% |
596,665
+20,491
| +4% | +$1.32M |
|
119
Regeneron Pharmaceuticals
REGN
$78.4B
| $36.4M | 0.21% |
+71,405
| New | +$34.8M |
|
120
Sony
SONY
$132B
| $36.1M | 0.2% |
6,361,565
-4,727,675
| -43% | -$29M |
|
121
Community Health Systems
CYH
$416M
| $35.9M | 0.2% |
690,396
+3,333
| +0.5% | +$150K |
|
122
Nice
NICE
$5.97B
| $35.8M | 0.2% |
563,138
+82,976
| +17% | +$5.24M |
|
123
Unum
UNM
$14.3B
| $35.5M | 0.2% |
993,310
-292,635
| -23% | -$10.2M |
|
|
AET
124
DELISTED
Aetna Inc
AET
| $34.6M | 0.2% |
271,255
+33,300
| +14% | +$3.8M |
|
|
CYBR
125
DELISTED
CyberArk
CYBR
| $34.5M | 0.19% |
+548,714
| New | +$35.1M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.